These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 19894112)

  • 21. Predictors of cognitive decline after chemotherapy in breast cancer patients.
    Vearncombe KJ; Rolfe M; Wright M; Pachana NA; Andrew B; Beadle G
    J Int Neuropsychol Soc; 2009 Nov; 15(6):951-62. PubMed ID: 19709455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interest of a new instrument to assess cognition in schizophrenia: The Brief Assessment of Cognition in Schizophrenia (BACS)].
    Bralet MC; Navarre M; Eskenazi AM; Lucas-Ross M; Falissard B
    Encephale; 2008 Dec; 34(6):557-62. PubMed ID: 19081451
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
    Houthoofd SA; Morrens M; Sabbe BG
    Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Change in cognitive function after chemotherapy: a prospective longitudinal study in breast cancer patients.
    Schagen SB; Muller MJ; Boogerd W; Mellenbergh GJ; van Dam FS
    J Natl Cancer Inst; 2006 Dec; 98(23):1742-5. PubMed ID: 17148777
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Changes on bone mineral density after adjuvant treatment in women with non-metastatic breast cancer.
    Rodríguez-Rodríguez LM; Rodríguez-Rodríguez EM; Oramas-Rodríguez JM; Santolaria-Fernandez F; Llanos M; Cruz J; Martínez A; González-Reimers E; Gómez A; Batista N
    Breast Cancer Res Treat; 2005 Sep; 93(1):75-83. PubMed ID: 16184462
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Observation and clinical significance of adjuvant chemotherapy-induced amenorrhea in premenopausal breast cancer patients].
    Li HP; Ma LW; Zhang SL; Jia TZ; Deng HJ; Zhang ZH; Liang L; Wang MP; Xiao Y; Cao BS; Chen S; Wang YF
    Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):848-51. PubMed ID: 17416008
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered frontocortical, cerebellar, and basal ganglia activity in adjuvant-treated breast cancer survivors 5-10 years after chemotherapy.
    Silverman DH; Dy CJ; Castellon SA; Lai J; Pio BS; Abraham L; Waddell K; Petersen L; Phelps ME; Ganz PA
    Breast Cancer Res Treat; 2007 Jul; 103(3):303-11. PubMed ID: 17009108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Electrophysiological correlates of information processing in breast-cancer patients treated with adjuvant chemotherapy.
    Kreukels BP; Schagen SB; Ridderinkhof KR; Boogerd W; Hamburger HL; van Dam FS
    Breast Cancer Res Treat; 2005 Nov; 94(1):53-61. PubMed ID: 16175317
    [TBL] [Abstract][Full Text] [Related]  

  • 29. No indications of cognitive side-effects in a prospective study of breast cancer patients receiving adjuvant chemotherapy.
    Mehlsen M; Pedersen AD; Jensen AB; Zachariae R
    Psychooncology; 2009 Mar; 18(3):248-57. PubMed ID: 18756583
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A metaanalysis of studies of the effects of cancer chemotherapy on various domains of cognitive function.
    Jansen CE; Miaskowski C; Dodd M; Dowling G; Kramer J
    Cancer; 2005 Nov; 104(10):2222-33. PubMed ID: 16206292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short-term effects of treatment-induced hormonal changes on cognitive function in breast cancer patients: results of a multicenter, prospective, longitudinal study.
    Hermelink K; Henschel V; Untch M; Bauerfeind I; Lux MP; Munzel K
    Cancer; 2008 Nov; 113(9):2431-9. PubMed ID: 18823033
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cognitive impairment associated with adjuvant therapy in breast cancer.
    Bender CM; Sereika SM; Berga SL; Vogel VG; Brufsky AM; Paraska KK; Ryan CM
    Psychooncology; 2006 May; 15(5):422-30. PubMed ID: 16097037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cognitive side-effects of adjuvant treatments.
    Burstein HJ
    Breast; 2007 Dec; 16 Suppl 2():S166-8. PubMed ID: 17719225
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cognitive deficits as long-term side-effects of adjuvant therapy in breast cancer patients: 'subjective' complaints and 'objective' neuropsychological test results.
    Weis J; Poppelreuter M; Bartsch HH
    Psychooncology; 2009 Jul; 18(7):775-82. PubMed ID: 19061196
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cognitive effects of hormonal therapy in early stage breast cancer patients: a prospective study.
    Collins B; Mackenzie J; Stewart A; Bielajew C; Verma S
    Psychooncology; 2009 Aug; 18(8):811-21. PubMed ID: 19085975
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The influence of erythropoietin on cognitive function in women following chemotherapy for breast cancer.
    Fan HG; Park A; Xu W; Yi QL; Braganza S; Chang J; Couture F; Tannock IF
    Psychooncology; 2009 Feb; 18(2):156-61. PubMed ID: 18561284
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive functioning after adjuvant chemotherapy and/or radiotherapy for early-stage breast carcinoma.
    Donovan KA; Small BJ; Andrykowski MA; Schmitt FA; Munster P; Jacobsen PB
    Cancer; 2005 Dec; 104(11):2499-507. PubMed ID: 16247788
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prophylactic Oophorectomy: Reducing the U.S. Death Rate from Epithelial Ovarian Cancer. A Continuing Debate.
    Piver MS
    Oncologist; 1996; 1(5):326-330. PubMed ID: 10388011
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive deficits in Korean women treated with chemotherapy for breast cancer.
    Jung MS; Cimprich B
    Cancer Nurs; 2014; 37(3):E31-42. PubMed ID: 23945143
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.